PL2695611T3 - Eprotirom do stosowania w profilaktyce i/lub leczeniu zaburzeń włosów oraz jego kompozycje - Google Patents

Eprotirom do stosowania w profilaktyce i/lub leczeniu zaburzeń włosów oraz jego kompozycje

Info

Publication number
PL2695611T3
PL2695611T3 PL12179384T PL12179384T PL2695611T3 PL 2695611 T3 PL2695611 T3 PL 2695611T3 PL 12179384 T PL12179384 T PL 12179384T PL 12179384 T PL12179384 T PL 12179384T PL 2695611 T3 PL2695611 T3 PL 2695611T3
Authority
PL
Poland
Prior art keywords
eprotirome
prevention
compositions
treatment
hair disorders
Prior art date
Application number
PL12179384T
Other languages
English (en)
Inventor
Michael Soeberdt
Ulrich Knie
Christoph Abels
Original Assignee
Dr August Wolff Gmbh & Co Kg Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr August Wolff Gmbh & Co Kg Arzneimittel filed Critical Dr August Wolff Gmbh & Co Kg Arzneimittel
Publication of PL2695611T3 publication Critical patent/PL2695611T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
PL12179384T 2012-08-06 2012-08-06 Eprotirom do stosowania w profilaktyce i/lub leczeniu zaburzeń włosów oraz jego kompozycje PL2695611T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12179384.8A EP2695611B1 (en) 2012-08-06 2012-08-06 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof

Publications (1)

Publication Number Publication Date
PL2695611T3 true PL2695611T3 (pl) 2015-03-31

Family

ID=46963380

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12179384T PL2695611T3 (pl) 2012-08-06 2012-08-06 Eprotirom do stosowania w profilaktyce i/lub leczeniu zaburzeń włosów oraz jego kompozycje

Country Status (16)

Country Link
US (1) US20150182482A1 (pl)
EP (1) EP2695611B1 (pl)
JP (1) JP6125012B2 (pl)
KR (1) KR20150039824A (pl)
CN (1) CN104717964A (pl)
AU (1) AU2013301601B2 (pl)
BR (1) BR112015002540A2 (pl)
CA (1) CA2879847C (pl)
DK (1) DK2695611T3 (pl)
ES (1) ES2528392T3 (pl)
HK (1) HK1206598A1 (pl)
MX (1) MX350125B (pl)
PL (1) PL2695611T3 (pl)
RU (1) RU2015107846A (pl)
SG (1) SG11201500838UA (pl)
WO (1) WO2014023698A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11091467B2 (en) 2019-05-08 2021-08-17 Aligos Therapeutics, Inc. Modulators of THR-β and methods of use thereof
CN111110600B (zh) * 2019-12-31 2021-08-06 泉后(深圳)信息技术有限公司 一种头皮净化促生发组合物及其乳液

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE159515T1 (de) * 1992-07-21 1997-11-15 Ciba Geigy Ag Oxamidsäure-derivate als hypocholesterämische mittel
WO1996025943A1 (en) 1995-02-23 1996-08-29 Life Medical Sciences, Inc. Compositions and methods for enhancing the growth of hair and restoring hair color
JP2003500459A (ja) 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター 置換バイアリールエーテル化合物
CA2374266A1 (en) * 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
AU3507700A (en) 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using diphenylether derivatives
MXPA01012494A (es) 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Metodo para tratar perdida capilar con el uso de compuestos sulfonil tiromimeticos.
EP1194422A1 (en) 1999-06-01 2002-04-10 University Of Texas Southwestern Medical Center Biaryl compounds
CA2374262A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss
AU2001230929B2 (en) 2000-02-17 2004-09-23 Bristol-Myers Squibb Co. Aniline-derived ligands for the thyroid receptor
IL151376A0 (en) 2000-03-31 2003-04-10 Pfizer Prod Inc Malonamic acids and derivatives thereof as thyroid receptor ligands
ES2267945T3 (es) 2001-05-31 2007-03-16 Pfizer Products Inc. Uso medico de compuestos tiromimeticos para tratar la perdida del cabello y composiciones.
ATE313325T1 (de) 2001-09-26 2006-01-15 Pfizer Prod Inc Indolcaroboxylsäure als thyroidrezeptor-liganden
US6806381B2 (en) 2001-11-02 2004-10-19 Bristol-Myers Squibb Company Process for the preparation of aniline-derived thyroid receptor ligands
US7230031B2 (en) 2002-01-30 2007-06-12 Kissei Pharmaceutical Co., Ltd. Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
US7812299B2 (en) 2005-07-22 2010-10-12 Nikon Corporation Image sensor having two-dimensionally arrayed pixels, focus detecting device using the sensor, and imaging system including the sensor
JP4810151B2 (ja) 2005-07-22 2011-11-09 出光興産株式会社 イネの育苗時期に発生する病害に対する防除剤
GB0606201D0 (en) 2006-03-28 2006-05-10 Karobio Ab Improved crytalline material
EP2036887A1 (en) 2006-06-28 2009-03-18 Sanwa Kagaku Kenkyusho Co., Ltd Novel 6-5 bicycic heterocyclic derivative and medical use thereof
GB0724478D0 (en) 2007-12-14 2008-01-30 Karobio Ab Pharmaceutical compositions
GB0725214D0 (en) 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
JP2009155261A (ja) 2007-12-26 2009-07-16 Sanwa Kagaku Kenkyusho Co Ltd 新規インドール誘導体及びその医薬用途
EP2609910A1 (en) * 2011-12-30 2013-07-03 Deva Holding Anonim Sirketi Formulations of eprotirome

Also Published As

Publication number Publication date
JP2015524458A (ja) 2015-08-24
MX350125B (es) 2017-08-28
WO2014023698A1 (en) 2014-02-13
SG11201500838UA (en) 2015-03-30
RU2015107846A (ru) 2016-09-27
BR112015002540A2 (pt) 2017-12-12
JP6125012B2 (ja) 2017-05-10
AU2013301601A1 (en) 2015-02-05
KR20150039824A (ko) 2015-04-13
EP2695611B1 (en) 2014-10-01
MX2015001670A (es) 2015-04-10
CN104717964A (zh) 2015-06-17
ES2528392T3 (es) 2015-02-09
AU2013301601B2 (en) 2016-09-01
DK2695611T3 (en) 2015-01-05
EP2695611A1 (en) 2014-02-12
CA2879847A1 (en) 2014-02-13
US20150182482A1 (en) 2015-07-02
HK1206598A1 (en) 2016-01-15
CA2879847C (en) 2017-10-03

Similar Documents

Publication Publication Date Title
HK1249861A1 (zh) 治療血紅蛋白病的組合物和方法
HRP20181364T1 (hr) Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
IL239355A0 (en) Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders
IL225239A0 (en) Compounds for the treatment of acne and related diseases
LT2854910T (lt) Ceramido lygiai infekcijos gydymo ir prevencijos metu
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
HK1211221A1 (en) Formulations for the treatment and prevention of obesity
ZA201408055B (en) Compositions and methods for the treatment of local pain
IL233875A (en) Preparation and use for the treatment of anal fissures
EP2897621A4 (en) COMPOUNDS AND COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES, PAIN AND FEVER, SKIN DISEASES, CANCER AND PRECULTURAL INJURIES
HK1207289A1 (en) Composition for prevention of vasoactivity in the treatment of blood loss and anemia
HK1200353A1 (zh) 用於預防或治療情感障礙的 -取代的苯丙酰胺或苯丙烯酰胺
HK1206598A1 (en) Eprotirome for use in the prevention and or treatment of hair disorders and compositions thereof